Terms: = Lymphoma AND AFF1, MLLT2, 4299, ENSG00000172493, P51825, AF-4, PBM1
72 results:
1. Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
Wu JR; Shih PC; Li C; Chao HL; Wang HC; Chiang YM; Liu YJ; Hsu SC; Yao CY; Chen LH; Lin CC; Tien HF; Chou WC
J Hematop; 2023 Jun; 16(2):103-109. PubMed ID: 38175441
[TBL] [Abstract] [Full Text] [Related]
2. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V; Valsecchi MG; Cario G; Zimmermann M; Attarbaschi A; Stary J; Niggli F; Dalla Pozza L; Elitzur S; Silvestri D; Locatelli F; Möricke A; Engstler G; Smisek P; Bodmer N; Barbaric D; Izraeli S; Rizzari C; Boos J; Buldini B; Zucchetti M; von Stackelberg A; Matteo C; Lehrnbecher T; Lanvers-Kaminsky C; Cazzaniga G; Gruhn B; Biondi A; Schrappe M
J Clin Oncol; 2024 Mar; 42(8):915-926. PubMed ID: 38096462
[TBL] [Abstract] [Full Text] [Related]
3. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::aff1 fusion.
Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
[TBL] [Abstract] [Full Text] [Related]
4. Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-aff1 fusion.
Pan F; Sarno J; Jeong J; Yang X; Jager A; Gruber TA; Davis KL; Cleary ML
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917159
[TBL] [Abstract] [Full Text] [Related]
5. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
[TBL] [Abstract] [Full Text] [Related]
6. The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome.
Külp M; Larghero P; Alten J; Cario G; Eckert C; Caye-Eude A; Cavé H; Schmachtel T; Bardini M; Cazzaniga G; De Lorenzo P; Valsecchi MG; Bonig H; Meyer C; Rieger MA; Marschalek R
Leukemia; 2023 Jun; 37(6):1216-1233. PubMed ID: 37100882
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive landscape of transcription profiles and data resources for human leukemia.
Luo M; Miao YR; Ke YJ; Guo AY; Zhang Q
Blood Adv; 2023 Jul; 7(14):3435-3449. PubMed ID: 36595475
[TBL] [Abstract] [Full Text] [Related]
8. Ocular adnexal lymphoma: Subtype-specific clinical and genetic features.
Kirkegaard MK
Acta Ophthalmol; 2022 Oct; 100 Suppl 270():3-37. PubMed ID: 36196757
[TBL] [Abstract] [Full Text] [Related]
9. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Isobe T; Takagi M; Sato-Otsubo A; Nishimura A; Nagae G; Yamagishi C; Tamura M; Tanaka Y; Asada S; Takeda R; Tsuchiya A; Wang X; Yoshida K; Nannya Y; Ueno H; Akazawa R; Kato I; Mikami T; Watanabe K; Sekiguchi M; Seki M; Kimura S; Hiwatari M; Kato M; Fukuda S; Tatsuno K; Tsutsumi S; Kanai A; Inaba T; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Kotecha RS; Cruickshank MN; Ishikawa F; Morio T; Eguchi M; Deguchi T; Kiyokawa N; Arakawa Y; Koh K; Aoki Y; Ishihara T; Tomizawa D; Miyamura T; Ishii E; Mizutani S; Wilson NK; Göttgens B; Miyano S; Kitamura T; Goyama S; Yokoyama A; Aburatani H; Ogawa S; Takita J
Nat Commun; 2022 Aug; 13(1):4501. PubMed ID: 36042201
[TBL] [Abstract] [Full Text] [Related]
10. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Moorman AV; Barretta E; Butler ER; Ward EJ; Twentyman K; Kirkwood AA; Enshaei A; Schwab C; Creasey T; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Marks DI; Fielding AK
Leukemia; 2022 Mar; 36(3):625-636. PubMed ID: 34657128
[TBL] [Abstract] [Full Text] [Related]
12. Genetic and Epigenetic Characterization of a Discordant
Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904
[TBL] [Abstract] [Full Text] [Related]
13. Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience.
Richard-Carpentier G; Kantarjian HM; Tang G; Yin CC; Khoury JD; Issa GC; Haddad F; Jain N; Ravandi F; Short NJ; DiNardo CD; Takahashi K; Konopleva MY; Daver NG; Kadia T; Garcia-Manero G; Garris R; O'Brien S; Jabbour E
Blood Adv; 2021 Dec; 5(23):5415-5419. PubMed ID: 34525185
[TBL] [Abstract] [Full Text] [Related]
14. [Acute leukemia of infants and neonates].
Eguchi M
Rinsho Ketsueki; 2021; 62(8):1308-1318. PubMed ID: 34497221
[TBL] [Abstract] [Full Text] [Related]
15. [Leukemogenic pathway of infant leukemia with MLL fusion].
Eguchi M
Rinsho Ketsueki; 2021; 62(7):809-819. PubMed ID: 34349066
[TBL] [Abstract] [Full Text] [Related]
16. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Paietta E; Roberts KG; Wang V; Gu Z; Buck GAN; Pei D; Cheng C; Levine RL; Abdel-Wahab O; Cheng Z; Wu G; Qu C; Shi L; Pounds S; Willman CL; Harvey R; Racevskis J; Barinka J; Zhang Y; Dewald GW; Ketterling RP; Alejos D; Lazarus HM; Luger SM; Foroni L; Patel B; Fielding AK; Melnick A; Marks DI; Moorman AV; Wiernik PH; Rowe JM; Tallman MS; Goldstone AH; Mullighan CG; Litzow MR
Blood; 2021 Sep; 138(11):948-958. PubMed ID: 33895809
[TBL] [Abstract] [Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/aff1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT.
Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A
Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481
[TBL] [Abstract] [Full Text] [Related]
18. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O
Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102
[TBL] [Abstract] [Full Text] [Related]
19. Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
Loftus JP; Yahiaoui A; Brown PA; Niswander LM; Bagashev A; Wang M; Schauf A; Tannheimer S; Tasian SK
Haematologica; 2021 Apr; 106(4):1067-1078. PubMed ID: 32414848
[TBL] [Abstract] [Full Text] [Related]
20. MLL-Rearranged Acute Lymphoblastic Leukemia.
El Chaer F; Keng M; Ballen KK
Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
[TBL] [Abstract] [Full Text] [Related]
[Next]
